NEOVACS (EPA:ALNEV) | WebDisclosure

BRIEF

published on 07/08/2025 at 18:35, 4 months 27 days ago

NEOVACS: Update of share capital and voting rights

Voting Rights Actions Funding Investments Émission
BRIEF

published on 07/08/2025 at 18:35, 4 months 27 days ago

NEOVACS : Mise à jour du capital social et des droits de vote

Droits De Vote Actions Financement Investissements Émission
PRESS RELEASE

published on 07/08/2025 at 18:30, 4 months 27 days ago

Information relative au nombre total de droits de vote et d'actions composant le capital social
Néovacs, société biopharmaceutique, publie le nombre d'actions et de droits de vote. Détails des actions émises mensuellement et activités R&D. Informations investisseurs et relations presse

Actions R&D Biopharmaceutique Investisseurs Néovacs
BRIEF

published on 07/03/2025 at 21:05, 5 months 1 day ago

Néovacs émet des obligations de 0,4 million d'euros

Actionnaires Emission D'obligations Financement Dilutif Equitization Fiducie-gestion
BRIEF

published on 07/03/2025 at 21:05, 5 months 1 day ago

Neovacs issues €0.4 million in bonds

Shareholders Bond Issue Dilutive Financing Equitization Trust Management
PRESS RELEASE

published on 07/03/2025 at 21:00, 5 months 1 day ago

Néovacs annonce une émission obligataire de 0,4 MEUR dans le cadre de son programme d'equitization
Néovacs annonce la première émission d'obligations simples et optimise son financement. L'equitization modifié permet une émission accélérée d'OS

Biotechnologie Financement Emission D'obligations Néovacs Equitization
BRIEF

published on 07/01/2025 at 08:05, 5 months 4 days ago

Néovacs cherche des investisseurs pour Arnity Therapeutics

Investissement Biotechnologies Néovacs Asthme Arnity Therapeutics
BRIEF

published on 07/01/2025 at 08:05, 5 months 4 days ago

Neovacs seeks investors for Arnity Therapeutics

Investment Biotechnologies Néovacs Asthma Arnity Therapeutics
PRESS RELEASE

published on 07/01/2025 at 08:00, 5 months 4 days ago

Néovacs intensifie son programme de business développement afin de faire entrer des investisseurs au capital de la société Arnity Therapeutics
Néovacs intensifie son programme de business développement pour l'entrée d'investisseurs au capital d'Arnity Therapeutics, société dédiée au développement pharmaceutique des actifs de Neovacs

Investisseurs Développement Pharmaceutique Néovacs Arnity Therapeutics Business Développement
BRIEF

published on 06/03/2025 at 18:35, 6 months 1 day ago

NEOVACS: Update on voting rights and share capital

Voting Rights Actions OCEANE Dilutive Financing Néovacs

1 2 ... 9

Published on 12/05/2025 at 02:35, 6 hours 41 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 6 hours 46 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 8 hours 16 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 11 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 16 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

Published on 12/05/2025 at 09:05, 10 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 15 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 15 minutes ago

SPECTRIS PLC - Removal
Published on 12/05/2025 at 09:00, 15 minutes ago

Official List Notice
Published on 12/05/2025 at 09:00, 15 minutes ago

Petershill Partners plc - Removal

View all EQS

Published on 12/05/2025 at 08:45, 31 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 31 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 33 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 15 hours 1 minute ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 15 hours 16 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE

News